This research program combines biomedical engineering efforts at Riverside Research Institute (RRI) and biological and medical investigations at Cornell University Medical College (CUMC) to improve the treatment of ocular tumors and help to assess the safety of diagnostic ultrasound techniques being applied to ophthalmology. To achieve these goals, the proposed research addresses a number of fundamental phenomena involved in the propagation of intense ultrasound and its interaction with tissue structures. Therapy applications involve the development of intense, short-term ultrasound exposures to treat substantial tumor volumes before-flow cooling and attendant uncertainties become significant. Special ultrasound ablation techniques involve adaptable beams to produce immediate changes in resistant tumor regions. A comprehensive computer simulation provides a model of relevant beam propagation and tissue heating. In-vivo ultrasonic tissue characterization techniques and 3-D scanning are used together with histopathology and biologic assay to characterize induced therapeutic changes. In-vitro, in-vivo, and clinical procedures are conducted to improve the technique and to verify model predictions. Safety studies involve ultrasonic pulsed Doppler exposures of the eye, with particular attention to the potential for thermal damage in the absorptive, avascular ocular lens. Very-high-resolution (VHR) ultrasound systems, which can resolve fine-scale microstructure (e.g., 30-micro m dimensions), are also under study; these systems apply frequencies (e.g., 50 MHz and above) that are much higher than those previously used in biological-effects experiments. They safety studies are intended to identify procedures and design criteria needed to support the continued development and safe use of modern ultrasonic capabilities. While these investigations involve practical needs in ophthalmology, they provide fundamental information regarding non-invasive tumor therapy and diagnostic safety for a broad spectrum of medical applications.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY010369-01
Application #
2164189
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1994-04-01
Project End
1997-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Riverside Research Institute
Department
Type
DUNS #
046822615
City
New York
State
NY
Country
United States
Zip Code
10038
Lizzi, Frederic L; Muratore, Robert; Deng, Cheri X et al. (2003) Radiation-force technique to monitor lesions during ultrasonic therapy. Ultrasound Med Biol 29:1593-605
Deng, Cheri X; Lizzi, Frederic L (2002) A review of physical phenomena associated with ultrasonic contrast agents and illustrative clinical applications. Ultrasound Med Biol 28:277-86
Silverman, R H; Lizzi, F L; Ursea, B G et al. (2001) Safety levels for exposure of cornea and lens to very high-frequency ultrasound. J Ultrasound Med 20:979-86
Deng, C X; Lizzi, F L; Kalisz, A et al. (2000) Study of ultrasonic contrast agents using a dual-frequency band technique. Ultrasound Med Biol 26:819-31
Lizzi, F L; Deng, C X; Lee, P et al. (1999) A comparison of ultrasonic beams for thermal treatment of ocular tumors. Eur J Ultrasound 9:71-8
Deng, C X; Lizzi, F L; Silverman, R H et al. (1998) Imaging and spectrum analysis of contrast agents in the in vivo rabbit eye using very-high-frequency ultrasound. Ultrasound Med Biol 24:383-94
Coleman, D J; Silverman, R H; Ursea, R et al. (1997) Ultrasonically induced hyperthermia for adjunctive treatment of intraocular malignant melanoma. Retina 17:109-17